at what moment is the goal that moves the world

A dream that scientists around the world are trying to realize. The challenge of developing a vaccine to end cancer This continues to be one of the expected reports from researchers, especially as they see what happened with covid in historical times.

It was the quick method of obtaining a vial against the virus that called into question the investment intentions of the administrations in the fight against tumors.

The main problem is evident in the different types that exist. This is what makes it difficult to develop a common vaccine that is effective for everyone, although institutions such as the European Commission They advocate starting to use them in preventative tasks..

Some experts acknowledge that the goal is “early detection“, although they understand when they talk about what it is”it’s hard to beat cancer“because of his “genetics.” Thus, the emphasis is on treatment that justifiably increases survival.

Organizations such as CRIS Cancer Foundation They also claim that these therapeutic vaccines have been in the works for “years,” but it will take “I know the tumor very well“, what “until recently required expensive and complex technologies“But they are optimistic about the progress being made in developing anti-Covid vials, as well as precise sequencing methods.

When the world created a vaccine in 10 months

The Covid health crisis has completely changed the daily lives of many people, and administrations have been forced to take action on the issue and devote a significant portion of their scientific investment to developing a vaccine to combat the virus.

The development of vials against SARS-CoV-2 has broken all historical records. In just 10 months, the protection created by Pfizer and BioNtech went from idea to reality in less than a year.

What shocked the world, but also raised many doubts about the unprecedented scientific investment aimed at putting an end to, in this case, a respiratory virus. And who asked the same question: Why don’t we do the same for a disease that kills almost 10 million people every year?

Well, a lot of this is due to low investment compared to covid, but it is also due to the different types of tumors that exist.

The World Health Organization warned this Thursday that it estimates there will be 77% more cancer cases in 2050 than in 2022, affecting 35 million people.

Impact of Covid vaccines

Perhaps the only good thing that the Covid pandemic has brought is that scientists have been able to analyze almost more than ever, thanks to the millions of dollars of investment that different countries have made to end the health crisis.

Immunotherapy and messenger RNA platforms offer greater optimism. As happened, for example, in a recent study of melanoma or in a preliminary study of pancreatic cancer.

The tests have increased, but the tumor has nothing to do with the problems caused by the virus. Each cancer patient is different, so personalized vials need to be developed.

He Dr. J. Javier Gonzalez CervantesDirector of the Master’s Program in Oncology Nursing and Coordinator of the Department of Nursing at the European University of Valencia, assures that the key isearly detection of tumors“Hence the importance of using new technologies, detection programs and developing appropriate treatments for each patient,” he explains.

But he thinks the same way as other scientists and believes that “Cancer is difficult to eradicate because of its genetics“But we have increased the response to treatment, achieving more complete remission of the disease and increasing survival,” he adds.

Regarding the impact of Covid, he candidly points out that in the case of cancer, there are many types of tumors and that “obstructs the investigation“You have to keep in mind that there are different anatomopathological variations of each tumor, so the process becomes significantly more complicated,” he warns.

“Very interesting” moment to explore

The possible development of an effective cancer vaccine has been part of a debate that has intensified over the past four years. The interest is so great that even the European Commission itself presented a report last Wednesday in which it supports member states in their efforts to prevent this.

To this end, although they are not part of the overall plan, Brussels has emphasized the importance of promoting two that it considers key: the human papillomavirus (HPV) and the hepatitis B virus (HBV). Something that stands out because both pathogens are capable of causing tumors.

According to the European Union, around 40% of cancer cases are preventable and therefore increased investment is required. In the report they note that in 2021 only “5% of total health expenditure was allocated to prevention.“.

It was scientific research on the development of a vaccine against covid that sparked debate about whether it is already possible to obtain an effective vial against various types of tumors. The CRIS Cancer Foundation says this is “extremely challenging.”

In its statement, the organization acknowledged that these problems have forced vaccine developers to focus more on treatments. “Because a tumor can only grow if the immune system does not detect it or if the tumor manipulates the immune response, The purpose of these vaccines is for our defenses to recognize and destroy tumor cells.“they say.

The CRIS Foundation clarifies what you need to know to solve a difficult problem”What proteins does it have that distinguish it from other healthy cells?“, but insist that the pandemic has put us at a “very interesting moment” in the investigations.

“We can now consider developing therapeutic vaccines for people with many types of tumors. and if we know well which tumors patients have had, we can develop vaccines for patients who have had a tumor so that their immune system prevents a recurrence,” the organization clarifies, citing clinical trials on patients with lung cancer as an example. ,next to Oxford University.

For now, while efforts are focused on providing an answer that will end cancer, some experts are developing other assays to try to reduce the risks that lead to problems with tumors.

Dr. J. Javier Gonzalez Cervantes is an expert in research analyzing exercise and cancer. “For most cancer patients, physical exercise performed before, during and after the cancer process helps improve the quality of life of these patients. We must not forget that a healthy lifestyle reduces the risk of getting cancer.“, he reasons.

Achieving an effective cancer treatment with just a puncture appears to be closer than ever, although there is still a long way to go. The optimism is obvious, but despite giant steps, the solution to this problem remains unresolved.